Slide 1Cancer Prevention: Translational Research in Colon Cancer Matthew R. Young Gene Regulation Section Laboratory of Cancer Prevention CCR, NCI Slide 2 Translational Cancer…

1.Presented by - K Harish (10035) Rupam Ghosh (10075) Sandeep Satapathy (10079) Cancer Epigenetics: From Mechanism to Therapy 2. Cancer 3. Cellular Signaling of Cancer model…

1. Oxidative stress and metabolic dysregulation in RP     1   Loss of daylight vision in retinal degeneration: are oxidative stress and metabolic dysregulation to blame?…

1. Targeting p53 for Novel Anticancer Therapy Presented by- Diksha Kumari Anurag Chanda Anindita Biswas B.pharm ,4thyr,7th Semester Guru Nanak Institute of Pharmaceutical…

Slide 1 Cancer-inducing genes - CRGs (cooperation response genes) Paper Presentation 01.12.2008 Nadine Sündermann Slide 2 Cancer-inducing genes Oncogenes and/or the loss…

Slide 1 LYMPHOMA Dr Bruce Covell Slide 2 Each year in the UK about about 1500 people develop Hodgkin's disease, usually between 15-25 years of age. It can also develop…

New Developments in Cancer Treatment Dulcinea Quintana, MD Mortality Rates Goals of treatment 1 Cure Goal of treatment 2 Prolong life Goals of treatment 3 Improve Quality…

“Dominant-Negative ALK2 Allele Associates with Congenital Heart Defects”[Smith et. al, 2009] Presented by Arron Sikka & Anita Isama Highlights from Review Article…

LYMPHOMA Hodgkin`s Disease Non-Hodgkin`s Disease Acibadem University Acibadem Medical Faculty Paediatrics Department Ertugrul Eryilmaz MD Assistant Professor Paediatrics…

“Dominant-Negative ALK2 Allele Associates with Congenital Heart Defects”[Smith et. al, 2009] Presented by Arron Sikka & Anita Isama Highlights from Review Article…